RESÚMENES MARZO 2005

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Requiere estar conectado a internet. Haga un click en la información del journal)

 

Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression

Ian Hickie, Sharon Naismith, Philip B. Ward, Keelin Turner, Elizabeth Scott, Philip Mitchell, Kay Wilhelm, and Gordon Parker

The British Journal of Psychiatry (2005) 186: 197-202

Escitalopram in the treatment of social anxiety disorder. Randomised, placebo-controlled, flexible-dosage study

Siegfried Kasper, Dan J. Stein, Henrik Loft, Rico Nil

The British Journal of Psychiatry (2005) 186: 222-226

Risk of puerperal and non-puerperal recurrence of illness following bipolar affective puerperal (post-partum) psychosis

Emma Robertson, Ian Jones, Sayeed Haque, Roger Holder, Nick Craddock

The British Journal of Psychiatry (2005) 186: 258-259

How safe is lithium prescribing? Audit of a local prescribing framework and patient survey

Katherine J. Glover, David Lawley

Psychiatric Bulletin (2005) 29: 98-100

Differential time courses and specificity of amygdala activity in posttraumatic stress disorder subjects and normal control subjects

Xenia Protopopescu, Hong Pan, Oliver Tuescher, Marylene Cloitre, Martin Goldstein, Wolfgang Engelien, Jane Epstein, Yihong Yang, Jack Gorman, Joseph LeDoux, David Silbersweig and Emily Stern

Biological Psychiatry. Volume 57, Issue 5, 1 March 2005, Pages 464-473

 

Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder

George Bartzokis, Po H. Lu, Jana Turner, Jim Mintz and C. Scott Saunders

Biological Psychiatry. Volume 57, Issue 5, 1 March 2005, Pages 474-479

 

Low-dose tryptophan depletion in recovered depressed patients induces changes in cognitive processing without depressive symptoms

Gail Hayward, Guy M. Goodwin, Phil J. Cowen and Catherine J. Harmer

Biological Psychiatry. Volume 57, Issue 5, 1 March 2005, Pages 517-524

 

Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy

E. Sherwood Brown, Gary Stuard, Joshua D.M. Liggin, Nedim Hukovic, Alan Frol, Nafisa Dhanani, David A. Khan, Jala Jeffress, Gregory L. Larkin, Bruce S. McEwen, Randall Rosenblatt, Yolanda Mageto, Margaret Hanczyc and C. Munro Cullum

Biological Psychiatry. Volume 57, Issue 5, 1 March 2005, Pages 543-548

 

Neuroendocrine (HPA axis) and clinical correlates during fluvoxamine and amitriptyline treatment

Eugenia Rota, Roberta Broda, Luigi Cangemi, Giuseppe Migliaretti, Piero Paccotti, Carlo Rosso, Eugenio Torre, Patrizia Zeppegno and Paolo Portaleone

Psychiatry Research. Volume 133, Issues 2-3, 28 February 2005, Pages 281-284

 

IS MOOD CHEMISTRY?

Eero Castrén    

Nature Reviews Neuroscience 6, 241-246 (2005)

Nightmares and terminal insomnia in depressed patients with and without melancholic features

Lutfullah Besiroglu, Mehmet Yucel Agargun and Rifat Inci

Psychiatry Research. Volume 133, Issues 2-3, 28 February 2005, Pages 285-287

 

Suboptimal Antidepressant Use in the Elderly.
Wang, Philip S.; Schneeweiss, Sebastian; Brookhart, M. Alan; Glynn, Robert J.; Mogun, Helen; Patrick, Amanda R.; Avorn, Jerry

Journal of Clinical Psychopharmacology. 25(2):118-126, April 2005

Orphan Comparisons and Indirect Meta-analysis: A Case Study on Antidepressant Efficacy in Dysthymia Comparing Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, and Monoamine Oxidase Inhibitors by Using General Linear Models.
Ballesteros, Javier

Journal of Clinical Psychopharmacology. 25(2):127-131, April 2005

Cardiovascular Profile of Duloxetine, a Dual Reuptake Inhibitor of Serotonin and Norepinephrine.
Thase, Michael E.; Tran, Pierre V.; Wiltse, Curtis; Pangallo, Beth A.; Mallinckrodt, Craig; Detke, Michael J.

Journal of Clinical Psychopharmacology. 25(2):132-140, April 2005

A Meta-analytic Review of the Efficacy of Drug Treatment in Generalized Anxiety Disorder.
Mitte, Kristin; Noack, Peter; Steil, Regina; Hautzinger, Martin

Journal of Clinical Psychopharmacology. 25(2):141-150, April 2005

Efficacy of Pregabalin in the Treatment of Generalized Anxiety Disorder: Double-blind, Placebo-Controlled Comparison of BID versus TID Dosing.
Pohl, Robert B.; Feltner, Douglas E.; Fieve, Ronald R.; Pande, Atul C.

Journal of Clinical Psychopharmacology. 25(2):151-158, April 2005

Maintenance Therapy With Fluoxetine in Posttraumatic Stress Disorder: A Placebo-Controlled Discontinuation Study
Davidson, Jonathan R.T.; Connor, Kathryn M.; Hertzberg, Michael A.; Weisler, Richard H.; Wilson, William H.; Payne, Victoria M.

Journal of Clinical Psychopharmacology. 25(2):166-169, April 2005

Deep Brain Stimulation for Treatment-Resistant Depression

Helen S. Mayberg, Andres M. Lozano, Valerie Voon, Heather E. McNeely, David Seminowicz, Clement Hamani, Jason M. Schwalb and Sidney H. Kennedy

Neuron. Volume 45, Issue 5, 3 March 2005, Pages 651-660

 

Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine

A Szegedi, R Kohnen, A Dienel, M Kieser

BMJ  2005;330:503 (5 March)

 

Gender differences in the effects of family adversity on the risk of onset of DSM-III-R social phobia

David J. DeWit, Michelle Chandler-Coutts, David R. Offord, Gillian King, Janette McDougall, Jacqueline Specht and Shannon Stewart

Journal of Anxiety Disorders. Volume 19, Issue 5, 2005, Pages 479-502

 

Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies.
Einarson TR, Einarson A

Pharmacoepidemiol Drug Saf. 2005 Mar 1; [Epub ahead of print]

 

A Randomized Effectiveness Trial of Cognitive-Behavioral Therapy and Medication for Primary Care Panic Disorder

Peter P. Roy-Byrne, Michelle G. Craske, Murray B. Stein, Greer Sullivan, Alexander Bystritsky, Wayne Katon, Daniela Golinelli, Cathy D. Sherbourne

Arch Gen Psychiatry. 2005;62:290-298

 

Frontal-Striatal Dysfunction During Planning in Obsessive-Compulsive Disorder

Odile A. van den Heuvel, Dick J. Veltman, Henk J. Groenewegen, Danielle C. Cath, Anton J. L. M. van Balkom, Julie van Hartskamp, Frederik Barkhof, Richard van Dyck

Arch Gen Psychiatry. 2005;62:301-309

 

Pregnancy outcome of women exposed to bupropion during pregnancy: A prospective comparative study
Chun-Fai-Chan B, Koren G, Fayez I, Kalra S, Voyer-Lavigne S, Boshier A, Shakir S, Einarson A

Am J Obstet Gynecol. 2005 Mar;192(3):932-6

 

The influence of 4-week treatment with sertraline on the combined T3/TRH test in depressed patients

Schule C, Baghai TC, Alajbegovic L, Schwarz M, Zwanzger P, Eser D, Schaaf L, Moller HJ, Rupprecht R

Eur Arch Psychiatry Clin Neurosci. 2005 Mar 5; [Epub ahead of print]

 

Tachyphylaxis in Unipolar Major Depressive Disorder

David A. Solomon, Andrew C. Leon, Timothy I. Mueller, William Coryell, Jedediah J. Teres, Michael A. Posternak, Lewis L. Judd, Jean Endicott, and Martin B. Keller

J Clin Psychiatry 2005;66:283-290

 

Extended-Release Carbamazepine Capsules as Monotherapy for Acute Mania in Bipolar Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Richard H. Weisler, Paul E. Keck, Jr., Alan C. Swann, Andrew J. Cutler, Terence A. Ketter, and Amir H. Kalali, for the SPD417 Study Group

J Clin Psychiatry 2005;66:323-330

 

Double-Blind Treatment With Oral Morphine in Treatment-Resistant Obsessive-Compulsive Disorder

Lorrin M. Koran, Elias Aboujaoude, Kim D. Bullock, Bettina Franz, Nona Gamel, and Michael Elliott

J Clin Psychiatry 2005;66:353-359

 

Citalopram Versus Sertraline in Late-Life Nonmajor Clinically Significant Depression: A 1-Year Follow-Up Clinical Trial

Paola Rocca, Paolo Calvarese, Fabrizio Faggiano, Livio Marchiaro, Federica Mathis, Elisa Rivoira, Barbara Taricco, and Filippo Bogetto

J Clin Psychiatry 2005;66:360-369

 

Preliminary Observations on the Effectiveness of Levetiracetam in the Open Adjunctive Treatment of Refractory Bipolar Disorder

Robert M. Post, Lori L. Altshuler, Mark A. Frye, Trisha Suppes, Susan L. McElroy, Paul E. Keck, Jr., Gabriele S. Leverich, Ralph Kupka, Willem A. Nolen, David A. Luckenbaugh, Jorg Walden, and Heinz Grunze

J Clin Psychiatry 2005;66:370-374

 

Deep brain stimulation for refractory obsessive-compulsive disorder

James L. Abelson, George C. Curtis, Oren Sagher, Ronald C. Albucher, Mark Harrigan, Stephan F. Taylor, Brian Martis and Bruno Giordani

Biological Psychiatry. Volume 57, Issue 5, 1 March 2005, Pages 510-516

 

A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial

Bradley N. Gaynes, A. John Rush, Madhukar Trivedi, Stephen R. Wisniewski, G.K. Balasubramani, Donald C. Spencer, Timothy Petersen, Michael Klinkman, Diane Warden, Robert K. Schneider, Daniel B. Castro, Robert N. Golden

Gen Hosp Psychiatry. Vol 27, Issue 2, Pages 87-96 (March 2005)

 

Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine

Kamini L. Ho Pian, Harold J.G.M. van Megen, Nick F. Ramsey, René Mandl, Peter P. van Rijk, H.J. Wynne and Herman G.M. Westenberg

Psychiatry Research: Neuroimaging. Volume 138, Issue 2, 28 February 2005, Pages 89-97

 

Pharmacotherapy of post-traumatic stress disorder: a family practitioners guide to management of the disease

Martin A Katzman­Lukasz Struzik­Lisa L Vivian­Monica Vermani­Joanna C McBride­

Expert Review of Neurotherapeutics. January 2005, Vol. 5, No. 1, Pages 129-139

 

Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-α treatment

Stavroula Beratis, Aggeliki Katrivanou, Sophia Georgiou, Alexandra Monastirli, Efstathia Pasmatzi, Philippos Gourzis and Dionysios Tsambaos

Journal of Psychosomatic Research. Volume 58, Issue 1, January 2005, Pages 15-18

 

Antidepressant-Induced Sweating

Todd R Marcy, Mark L Britton

The Annals of Pharmacotherapy: Vol. 39, No. 4, pp. 748-752.

 

Efficacy and Tolerability of Hypericum Extract STW3 in Long-term Treatment with a Once-daily Dosage in Comparison with Sertraline
Gastpar M, Singer A, Zeller K

Pharmacopsychiatry. 2005 Mar;38(2):78-86

 

Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample

PERMINDER S. SACHDEV, RUTH A. PARSLOW, ORA LUX, CHRIS SALONIKAS, WEI WEN, DAYA NAIDOO, HELEN CHRISTENSEN and ANTHONY F. JORM

Psychological Medicine (2005), 35:4:529-538

 

Reversed diurnal variation in depression: associations with a differential antidepressant response, tryptophan:large neutral amino acid ratio and serotonin transporter polymorphisms

PETER R. JOYCE, RICHARD J. PORTER, ROGER T. MULDER, SUZANNE E. LUTY, JANICE M. McKENZIE, ALLISON L. MILLER and MARTIN A. KENNEDY

Psychological Medicine (2005), 35:4:511-517

 

Do venlafaxine XR and paroxetine equally influence negative and positive affect?

Gabriel S. Dichter, Andrew J. Tomarken, Cathryn M. Freid, Stephanie Addington and Richard C. Shelton

Journal of Affective Disorders. Volume 85, Issue 3 , April 2005, Pages 333-339

 

Diagnostic stability in bipolar disorder in clinical practise as according to ICD-10

Lars Vedel Kessing

Journal of Affective Disorders. Volume 85, Issue 3 , April 2005, Pages 293-299

 

Divalproex in the treatment of bipolar depression: a placebo-controlled study

Lori L. Davis, Al Bartolucci and Frederick Petty

Journal of Affective Disorders. Volume 85, Issue 3 , April 2005, Pages 259-266

 

Agitated “unipolar” depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy

Hagop S. Akiskal, Franco Benazzi, Giulio Perugi and Zoltán Rihmer

Journal of Affective Disorders. Volume 85, Issue 3 , April 2005, Pages 245-258

 

Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers

Alvaro Camacho, and Hagop S. Akiskal

Journal of Affective Disorders. Volume 85, Issues 1-2 , March 2005, Pages 217-230

 

The cyclothymic temperament in healthy controls and familially at risk individuals for mood disorder: endophenotype for genetic studies?

Pierre Chiaroni, E. -G. Hantouche, J. Gouvernet, J. -M. Azorin and H. S. Akiskal

Journal of Affective Disorders. Volume 85, Issues 1-2 , March 2005, Pages 135-145

 

Antidepressant Use During Pregnancy and the Rates of Spontaneous Abortions: A Meta-Analysis

Michiel EH Hemels, Adrienne Einarson, Gideon Koren, Krista L Lanctôt, Thomas R Einarson

The Annals of Pharmacotherapy. Published online, 22 March 2005

 

General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction
Tata LJ, West J, Smith C, Farrington P, Card T, Smeeth L, Hubbard R

Heart. 2005 Apr;91(4):465-71

 

'Bipolar missed states': the diagnosis and clinical salience of bipolar mixed states

Michael Berk; Seetal Dodd; Gin S. Malhi

Australian and New Zealand Journal of Psychiatry 2005; Volume: 39 Number: 4 Page: 215 - 221

 

Anatomical MRI abnormalities in bipolar disorder: do they exist and do they progress?

E. Serap Monkul; Gin S. Malhi; Jair C. Soares

Australian and New Zealand Journal of Psychiatry 2005; Volume: 39 Number: 4 Page: 222 - 226

 

Temporal stability of the dex/CRH test in patients with rapid-cycling bipolar I disorder: a pilot study

Stuart Watson; Jill M. Thompson; Navdeep Malik; I. Nicol Ferrier; Allan H. Young

Australian and New Zealand Journal of Psychiatry 2005;Volume: 39 Number: 4 Page: 244 - 248

 

Focal Brain Stimulation For Treatment – Resistant Depression:Transcranial Magnetic Stimulation,Vagus-Nerve Stimulation,and Deep-Brain Stimulation

Paul E.Holtzheimer III, and David H.Avery

Primary Psychiatry.2005;12(2):57-64

 

Neuroimaging and Depression with Inadequate Treatment Response

Frank Andrew Kozel, and Mark S.George

Primary Psychiatry.2005;12(2):30-35

 

Electroconvulsive Therapy in Treatment-Resistant Depression

Sanjay J.Mathew, Jonathan M.Amiel, and Harold A.Sackeim

Primary Psychiatry.2005;12(2):52-56

 

Treatment Options in Treatment-Resistant Depression

Jennifer Gotto, and Mark H.Rapaport

Primary Psychiatry.2005;12(2):42-50

 

Patient perspectives on the diagnosis, treatment, and management of bipolar disorder

Lydia Lewis

Bipolar Disord 2005: 7 (Suppl. 1): 33-37

 

Women are not the same as men: specific clinical issues for female patients with bipolar disorder
Curtis V.

Bipolar Disord 2005: 7 (Suppl. 1): 16-24

 

Barriers to the effective management of bipolar disorder: a survey of psychiatrists based in the UK and USA
Chengappa KNR, Williams P.

Bipolar Disord 2005: 7 (Suppl. 1): 38-42

 

Age at onset in bipolar affective disorders: a review
Leboyer M, Henry C, Paillere-Martinot M-L, Bellivier F.

Bipolar Disord 2005: 7: 111-118

 

Gender differences in bipolar disorder: age of onset, course, comorbidity, and symptom presentation
Kawa I, Carter JD, Joyce PR, Doughty CJ, Frampton CM, Wells JE, Walsh AES, Olds RJ.

Bipolar Disord 2005: 7: 119-125

 

Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia
Baethge C, Baldessarini RJ, Freudenthal K, Streeruwitz A, Bauer M, Bschor T.

Bipolar Disord 2005: 7: 136-145

 

Actigraphic assessment of circadian activity and sleep patterns in bipolar disorder
Jones SH, Hare DJ, Evershed K.

Bipolar Disord 2005: 7: 176-186

 

Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy
Swartz HA, Pilkonis PA, Frank E, Proietti JM, Scott J.

Bipolar Disord 2005: 7: 192-197

 

Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis

Jennifer L. Couturier

J Psychiatry Neurosci 2005;30(2):83-90

 

Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis

Jennifer L. Couturier

J Psychiatry Neurosci 2005;30(2):83-90

 

Depression and anxiety in women with early breast cancer: five year observational cohort study

Caroline Burgess, Victoria Cornelius, Sharon Love, Jill Graham, Michael Richards, Amanda Ramirez

BMJ  2005;330:702 (26 March)

 

Lamotrigine and the risk of malformations in pregnancy
Cunnington M, Tennis P; International Lamotrigine Pregnancy Registry Scientific Advisory Committee

Neurology. 2005 Mar 22;64(6):955-60

 

Neuropsychological effects of exposure to anticonvulsant medication in utero
Vinten J, Adab N, Kini U, Gorry J, Gregg J, Baker GA; Liverpool and Manchester Neurodevelopment Study Group

Neurology. 2005 Mar 22;64(6):949-54

 

Increased rate of major malformations in offspring exposed to valproate during pregnancy
Wyszynski DF, Nambisan M, Surve T, Alsdorf RM, Smith CR, Holmes LB; Antiepileptic Drug Pregnancy Registry

Neurology. 2005 Mar 22;64(6):961-5

 

Teratogenicity of sodium valproate

Rachel Alsdorf; Diego F Wyszynski

Expert Opinion on Drug Safety 2005, vol. 4, no. 2, pp. 345 - 353

 

Teratogenicity of antiepileptic drugs: state of the art: review
Tomson T, Battino D

Curr Opin Neurol. 2005 Apr;18(2):135-40

 

Potential effectiveness and safety of olanzapine in refractory panic disorder.
Hollifield M, Thompson PM, Ruiz JE, Uhlenhuth EH

Depress Anxiety. 2005 Mar 22; [Epub ahead of print]

 

Stability of DSM-IV criterion symptoms for major depressive disorder

Kelly L. Minor, Jennifer E. Champion and Ian H. Gotlib

Journal of Psychiatric Research. Volume 39, Issue 4, July 2005, Pages 415-420

.

Regresar a RESÚMENES MARZO 2005